The Trump administration in March deported one gang leader with knowledge of the deal with the Bukele government. Now the DOJ ...

The thrill of great science is all around us in North Texas, as our colleague Miriam Fauzia reminded us in a recent story ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

In this interview, Dominic Gostik, the CTO of PerkinElmer, discusses the launch of its newest product, QSight®.

On this Doctors’ Day, as we honour the dedication and expertise of healthcare professionals, it’s also an ideal time to shed light on a condition that affects millions silently—osteoarthritis. Often ...

In 2024 the NMPA designated the combination as a Breakthrough Therapy ... is a significant milestone in addressing the complex challenges of lung cancer treatment in China, where the EGFR mutation is ...

This discovery could revolutionize treatments ... and multiple sclerosis. The newly found mechanism acts as a checkpoint, allowing immune cells to differentiate between harmful invaders and the body's ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...